Concepedia

Brian W. Guzik

BW

Statistics

Publications

9

Citations

634

H-Index

9

Active since

2001

Affiliations

Harvard University(Current)

University of Virginia

Brigham and Women's Hospital

Advantagene (United States)

Celldex Therapeutics (United States)

Brian W. Guzik is an author at Harvard University specializing in oncology, cancer immunotherapy, and immunology.

Publications per year

2001–2022

9

Publications

9

Sam68 Enhances the Cytoplasmic Utilization of Intron-Containing RNA and Is Functionally Regulated by the Nuclear Kinase Sik/BRK

John H. Coyle, Brian W. Guzik, Yeou-Cherng Bor et al. · Molecular and Cellular Biology · 2002 · 106 citations · Full text

, , +17

NXT1 (p15) Is a Crucial Cellular Cofactor in TAP-Dependent Export of Intron-Containing RNA in Mammalian Cells

Brian W. Guzik, Lyne Lévesque, Susan Prasad et al. · Molecular and Cellular Biology · 2001 · 105 citations · Full text

, , +13

Tap and NXT promote translation of unspliced mRNA

Li Jin, Brian W. Guzik, Yeou-Cherng Bor et al. · Genes & Development · 2003 · 97 citations · Full text

, , +16

Phase I study of gene-mediated cytotoxic immunotherapy with AdV-tk as adjuvant to surgery and radiation for pediatric malignant glioma and recurrent ependymoma

Mark W. Kieran, Liliana Goumnerova, Peter Manley et al. · Neuro-Oncology · 2019 · 88 citations · Full text

, , +17

Preclinical investigation of combined gene-mediated cytotoxic immunotherapy and immune checkpoint blockade in glioblastoma

Maria C. Speranza, Carmela Passaro, Franz Ricklefs et al. · Neuro-Oncology · 2017 · 73 citations · Full text

, , +17

1–5 of 9